Comprehensive clinico-genetic analysis reveals prognostic factors of blastic plasmacytoid dendritic cell neoplasm
- PMID: 40065083
- DOI: 10.1111/bjh.20022
Comprehensive clinico-genetic analysis reveals prognostic factors of blastic plasmacytoid dendritic cell neoplasm
References
REFERENCES
-
- Facchetti FJD, Petrella T. Blastic plasmocytoid dendritic cell neoplasm. Lyon: IARC; 2008.
-
- Facchetti FPT, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2017.
-
- Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36(7):1703–1719.
-
- Pemmaraju N, Lane AA, Sweet KL, Stein AS, Vasu S, Blum W, et al. Tagraxofusp in blastic plasmacytoid dendritic‐cell neoplasm. N Engl J Med. 2019;380(17):1628–1637.
-
- Pemmaraju N, Sweet KL, Stein AS, Wang ES, Rizzieri DA, Vasu S, et al. Long‐term benefits of tagraxofusp for patients with blastic plasmacytoid dendritic cell neoplasm. J Clin Oncol. 2022;40(26):3032–3036.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources